Back to Search
ARTHUR PADILLA, M.D.
M.D.
Anesthesiology Physician
NPI: 1538104310IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
4301095820(MI)
Pain Medicine (Anesthesiology) Physician
Anesthesiology — Pain Medicine
Code: 207LP2900X
4301095820(MI)
CMS Specialties
PrimaryINTERVENTIONAL PAIN MANAGEMENT
Education
OTHER
Class of 1993
Research & Publications (20)
[Validity and reliability of the St George's Respiratory Questionnaire in adults with cystic fibrosis].
PMID 17397584·Arch Bronconeumol·2007
4-observational
Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
PMID 15946719·Toxicon·2005
4-observational
Experimental envenoming of mice with venom from the scorpion Centruroides limpidus limpidus: differences in mortality and symptoms with and without antibody therapy relating to differences in age, sex and strain of mouse.
PMID 12875869·Toxicon·2003
7-preclinical
An atypical protein disulfide isomerase from the protozoan parasite Leishmania containing a single thioredoxin-like domain.
PMID 12427741·J Biol Chem·2003
7-preclinical
Predictors of adverse events after percutaneous transluminal coronary angioplasty in a group of Hispanic patients.
PMID 11394217·P R Health Sci J·2001
8-other
In vitro antimicrobial effect of bacteriocin PsVP-10 in combination with chlorhexidine and triclosan against Streptococcus mutans and Streptococcus sobrinus strains.
PMID 19124118·Arch Oral Biol·2009
8-other
Removing the invariant salt bridge of parvalbumin increases flexibility in the AB-loop structure.
PMID 19622856·Acta Crystallogr D Biol Crystallogr·2009
7-preclinical
Second-generation highly potent and selective inhibitors of the hepatitis C virus NS3 serine protease.
PMID 19196021·J Med Chem·2009
7-preclinical
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profile.
PMID 19371095·J Med Chem·2009
7-preclinical
Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection.
PMID 19553540·J Immunol·2009
7-preclinical
NMR structure of rALF-Pm3, an anti-lipopolysaccharide factor from shrimp: model of the possible lipid A-binding site.
PMID 19107926·Biopolymers·2009
7-preclinical
Discovery of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with improved cellular potencies.
PMID 19481946·Bioorg Med Chem·2009
7-preclinical
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034.
PMID 18547808·Bioorg Med Chem Lett·2008
8-other
Social cognition, ethnic identity, and ethnic specific strategies for coping with threat due to prejudice and discrimination.
PMID 18232129·Nebr Symp Motiv·2008
8-other
Lead exposures in U.S. Children, 2008: implications for prevention.
PMID 18941567·Environ Health Perspect·2008
8-other
Intrinsic viscosity of bovine serum albumin conformers.
PMID 18022223·Int J Biol Macromol·2008
7-preclinical
Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death.
PMID 17292476·Neurotoxicology·2007
7-preclinical
Frightened in isolation: unique considerations for research of sexual assault and interpersonal violence in rural areas.
PMID 17479565·J Forensic Nurs·2007
6-review
Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein-protein complexes.
PMID 17563369·Proc Natl Acad Sci U S A·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3333 EVERGREEN DR NE
GRAND RAPIDS, MI 49525 - Phone
- (616) 364-4200
Quick Facts
- NPI
- 1538104310
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile